1. 1496PIntracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Wakelee, H; Reckamp, K L; Leal, T A; Patel, S P; Blumenschein, G; Shum, E; Nieva, J; Oxnard, G; Sanborn, R E; Waqar, S; Zeman, K; Dukart, G; Harrow, K; Liang, C; Holzhausen, A; Horn, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 105PDetection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292. (23rd October 2018) Authors: Besse, B; Subbiah, V; Drilon, A; Shah, M; Wirth, L J; Bauer, T M; Velcheti, V; Lakhani, N; Boni, V; Solomon, B J; Johnson, M; Park, K; Patel, J; Cabanillas, M E; Sherman, E; Zhu, E; Gordon, K; Ebata, K; Tuch, B; Oxnard, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA2TATTON expansion cohorts: A phase Ib study of osimertinib plus savolitinib in patients (pts) with EGFR-mutant, MET-positive NSCLC following disease progression on a prior EGFR-TKI. (24th November 2019) Authors: Han, J-Y; Sequist, L V; Ahn, M-J; Cho, B C; Yu, H; Kim, S-W; Yang, J C-H; Lee, J S; Su, W-C; Kowalski, D; Orlov, S; Cantarini, M; Verheijen, R B; Mellemgaard, A; Frewer, P; Ou, X; Oxnard, G Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗